Central Holding Group Co. Ltd. (1735.HK) Bundle
Central Holding Group Co. Ltd. (1735.HK) is riding a powerful top-line surge-revenues jumped to HK$6.03 billion in FY2024, a 49.74% increase from HK$4.03 billion, and continued momentum into 1H2025 with HK$4.05 billion (a 59.9% YoY rise)-driven by New Energy and Health & Wellness but juxtaposed with mixed profitability and liquidity signals; FY2024 net income was HK$106.39 million while trailing EPS is HK$0.02 and the trailing P/E sits at 384.23, even as operating cash flow for the TTM is a -HK$780.50 million drain, free cash flow is -HK$858.95 million, total debt stands at HK$331.73 million with cash of HK$176.86 million (net cash ~HK$51.22 million) yet the debt-to-equity ratio is a high 267.13%, interest coverage is negative at -9.30, and valuation contrasts-market cap HK$34.21 billion, enterprise value HK$36.09 billion versus a Peter Lynch fair value of HK$0.53 and a market price of HK$7.98-making this a complex risk/reward story as the company pivots to high-efficiency PV production, health-related services and ancillary businesses; continue reading for detailed breakdowns on revenue drivers, profitability metrics, leverage, liquidity pressures, valuation multiples and growth catalysts through 2026.
Central Holding Group Co. Ltd. (1735.HK) - Revenue Analysis
Central Holding Group Co. Ltd. (1735.HK) recorded marked top-line expansion through 2024 and into H1 2025 as it rebalanced its business mix toward New Energy and Health & Wellness. The following points and table capture the key revenue figures, segment drivers, and the operational implications of that growth.
- Fiscal 2024 total revenue: HK$6.03 billion - a 49.74% increase from HK$4.03 billion in 2023.
- H1 2025 revenue: HK$4.05 billion - a 59.9% year-over-year increase versus H1 2024, signalling accelerating momentum.
- Primary growth drivers: New Energy (high-efficiency PV batteries and component production) and Health & Wellness segments.
- Strategic shift in 2025: scaled back green construction; prioritized renewable energy manufacturing and related high-margin components.
- Despite revenue gains, historical net losses persist, indicating difficulties converting top-line growth into consistent profitability.
- Diversification into ancillary businesses (F&B supply, health products) intended to capture value across the construction lifecycle increases addressable market but raises execution and integration risk.
| Period | Revenue (HK$ billion) | YoY Growth | Key Drivers |
|---|---|---|---|
| 2023 (FY) | 4.03 | - | Mixed: construction, early-stage new energy |
| 2024 (FY) | 6.03 | +49.74% | New Energy expansion; Health & Wellness ramp-up |
| H1 2024 | (implied) 2.53 | - | Base period |
| H1 2025 | 4.05 | +59.9% YoY | Scale-up of high-efficiency PV production; reduced green construction |
- Margin and profitability dynamics:
- Revenue mix shifting toward manufacturing (PV batteries/components) can improve gross margins over time if scale and cost controls hold.
- However, prior net losses indicate ongoing issues: operating leverage, start-up costs for new units, inventory or working-capital pressure, or pricing competition in PV supply chains.
- Risk considerations:
- Execution risk across multiple sectors (renewables manufacturing, health products, F&B supply) could dilute management focus and capital allocation.
- Supply-chain volatility and commodity pricing for PV inputs could compress margins despite higher revenue.
- Transitioning away from green construction reduces revenue diversification and concentrates exposure on manufacturing execution.
For a concise statement of the group's forward-looking priorities and values that frame this revenue strategy, see: Mission Statement, Vision, & Core Values (2026) of Central Holding Group Co. Ltd.
Central Holding Group Co. Ltd. (1735.HK) - Profitability Metrics
- Net income (FY ending 31 Dec 2024): HK$106.39 million (+60.42% vs HK$66.32 million in prior year)
- Trailing twelve months (TTM) EPS: HK$0.02; P/E ratio: 384.23
- Return on equity (ROE): -0.16%
- Return on invested capital (ROIC): -4.58%
- Operating income (TTM): -HK$29.95 million
- Gross profit margin: improved from 1.7% to 2.1%
- Historical context: revenue growth present, but prior fiscal-year net losses indicate challenges converting top-line growth into consistent profitability
| Metric | Value | Period / Note |
|---|---|---|
| Net Income | HK$106.39 million | FY 2024 (+60.42% YoY) |
| EPS (TTM) | HK$0.02 | Trailing twelve months |
| P/E Ratio | 384.23 | Market price relative to TTM EPS |
| ROE | -0.16% | TTM |
| ROIC | -4.58% | TTM |
| Operating Income | -HK$29.95 million | TTM (operational loss) |
| Gross Profit Margin | 2.1% | Improved from 1.7% |
- Implication: high P/E (384.23) versus low EPS (HK$0.02) signals elevated market expectations; negative ROE and ROIC highlight difficulty in converting equity and invested capital into positive returns.
- Operating loss (-HK$29.95m) despite positive net income in 2024 suggests non-operating items or one-time gains contributed to the net result-investors should examine the income statement and notes for non-recurring items.
- Marginal gross margin improvement (1.7% → 2.1%) indicates some cost control gains but remains thin, leaving profitability sensitive to revenue swings and expense volatility.
Central Holding Group Co. Ltd. (1735.HK) - Debt vs. Equity Structure
Central Holding Group Co. Ltd. (1735.HK) presents a capital structure characterized by high leverage on an equity basis but with mixed liquidity signals. Below are the core metrics investors should weigh when assessing solvency, short-term funding resilience, and overall enterprise valuation.
- Total debt: HK$331.73 million
- Cash and cash equivalents: HK$176.86 million
- Reported net cash position: HK$51.22 million
- Debt-to-equity ratio: 267.13%
- Current ratio: 1.31
- Quick ratio: 1.18
- Enterprise value (EV): HK$36.09 billion
- Net debt / EBITDA: 2.64
Key takeaways from these metrics:
- A debt-to-equity ratio of 267.13% signals that debt far exceeds shareholders' equity, implying higher financial risk if earnings or cash flows deteriorate.
- Current and quick ratios above 1 (1.31 and 1.18) indicate the company can cover short-term liabilities with current assets and near-cash assets without relying on inventory conversion.
- Net debt/EBITDA at 2.64 is within many lenders' moderate leverage thresholds, suggesting earnings could cover debt service over a few years, but this depends on EBITDA stability.
- Enterprise value of HK$36.09 billion reflects market valuation including debt; the large EV relative to reported debt suggests market assigns significant value to operations, assets, or growth prospects despite leverage.
| Metric | Value | Interpretation |
|---|---|---|
| Total debt | HK$331.73 million | Nominal outstanding interest-bearing obligations |
| Cash & cash equivalents | HK$176.86 million | Immediate liquidity buffer |
| Net cash position (reported) | HK$51.22 million | Reported surplus after accounting adjustments |
| Debt-to-equity | 267.13% | High leverage vs. equity base |
| Current ratio | 1.31 | Short-term coverage adequate |
| Quick ratio | 1.18 | Immediate-liquidity coverage adequate without inventory |
| Net debt / EBITDA | 2.64 | Moderate leverage relative to operational earnings |
| Enterprise value (EV) | HK$36.09 billion | Market-implied total company value |
For additional investor-focused context and shareholder activity, see: Exploring Central Holding Group Co. Ltd. Investor Profile: Who's Buying and Why?
Central Holding Group Co. Ltd. (1735.HK) - Liquidity and Solvency
Central Holding Group's recent reported figures point to materially constrained liquidity and stressed solvency metrics for the reporting period.- Cash and bank balances declined to HK$129.0 million from HK$265.9 million at year-end 2024 - a reduction of HK$136.9 million, signaling weaker near-term liquidity.
- Operating cash flow (TTM): -HK$780.50 million, indicating persistent cash burn from core operations.
- Free cash flow (TTM): -HK$858.95 million, showing the business is consuming cash after capital expenditure.
- Interest coverage ratio: -9.30, meaning operating earnings are insufficient to cover interest expenses (negative coverage).
- Net cash position: HK$51.22 million, a small buffer to meet short-term obligations despite broader cash stress.
- Overall solvency is under pressure due to negative operating and free cash flow, raising concerns about funding operations and growth internally.
| Metric | Amount (HK$ million) | Notes |
|---|---|---|
| Cash & Bank Balances (YE 2024) | 265.9 | Reported year-end prior period |
| Cash & Bank Balances (Current) | 129.0 | Decrease of 136.9 vs YE 2024 |
| Operating Cash Flow (TTM) | -780.50 | Negative operating cash generation |
| Free Cash Flow (TTM) | -858.95 | Cash consumed after capex |
| Interest Coverage Ratio | -9.30 | Insufficient earnings to cover interest |
| Net Cash Position | 51.22 | Small net cash buffer |
- Implications for investors:
- Short-term liquidity: weakened by the large reduction in cash balances and negative operating cash flow.
- Debt servicing: negative interest coverage suggests elevated refinancing or default risk if negative earnings persist.
- Capital strategy: negative free cash flow implies reliance on external financing (debt/equity) or asset disposals to fund operations and growth.
Central Holding Group Co. Ltd. (1735.HK) - Valuation Analysis
Central Holding Group's market multiples paint a picture of a stock priced for strong future performance but currently trading at lofty valuations relative to historical norms and book fundamentals. Key headline metrics are summarized below and then unpacked for investor context.| Metric | Value | Implication |
|---|---|---|
| Trailing P/E | 384.23 | Extremely high price relative to last 12 months' earnings |
| Forward P/E | 73.64 | Market expects sizable earnings growth vs. trailing |
| Price-to-Sales (P/S) | 4.47 | Investors pay premium per revenue dollar |
| Price-to-Book (P/B) | 25.57 | Market values equity far above book value |
| EV/Revenue | 5.95 | Enterprise-level premium on revenue streams |
| EV/EBITDA | 475.45 | Very high multiple on operating cash earnings |
| Peter Lynch Fair Value | HK$0.53 | Implied intrinsic value far below market price |
| Current Market Price | HK$7.98 | Market premium vs. Lynch-based fair value |
- High trailing P/E (384.23): indicates recent earnings are minimal relative to price or possibly one-off weakness in EPS; investors are pricing future earnings improvement.
- Forward P/E (73.64) materially lower than trailing P/E: consensus analysts anticipate earnings recovery/growth but still reflect a high premium for expected future profits.
- P/S of 4.47 and EV/Revenue 5.95: revenue is being valued at multiples typically seen for higher-growth or higher-margin peers - caution if growth doesn't materialize.
- P/B of 25.57: equity market cap far exceeds accounting book value, signaling high goodwill/intangible valuation or investor belief in superior return on equity going forward.
- EV/EBITDA at 475.45: suggests either EBITDA is currently very low (driving the ratio up) or the enterprise value is extreme relative to operating cash earnings; sensitive to small EBITDA base.
- Peter Lynch fair value HK$0.53 vs. market HK$7.98: by this simple valuation metric the stock appears substantially overvalued, implying large margin of safety concerns for value-oriented investors.
Interpretive notes for different investor profiles:
- Growth-oriented investors: The spread between trailing and forward P/E signals anticipated improvement; validate by checking revenue/earnings guidance, backlog, or catalysts supporting rapid EPS growth.
- Value-oriented investors: The P/B and Lynch fair value gap are red flags; require reassessment of balance sheet quality, intangible assets, and the sustainability of any above-average margins.
- Income/quality investors: Extremely high EV/EBITDA and P/E ratios warrant caution - assess cash flow stability, recurring revenue mix, and debt levels before considering exposure.
Practical next steps and data checks investors should perform:
- Confirm recent EPS trends and any one-off items that depress trailing earnings.
- Review analyst estimates underpinning the forward P/E and check consensus revision trends.
- Analyze EBITDA composition and seasonality to understand the extreme EV/EBITDA multiple.
- Reconcile book value components (intangibles, minority interests) to evaluate P/B meaningfully.
- Compare multiples to industry peers and to the company's historical valuation band.
For context on the company's strategic direction and qualitative drivers that may justify premium multiples, see: Mission Statement, Vision, & Core Values (2026) of Central Holding Group Co. Ltd.
Central Holding Group Co. Ltd. (1735.HK) - Risk Factors
Central Holding Group Co. Ltd. (1735.HK) presents a mix of operational transitions and financial strains that investors should weigh carefully. Key quantitative red flags and strategic exposures suggest elevated risk across liquidity, leverage, earnings coverage and execution.- Leverage: Debt-to-Equity Ratio - 267.13% (highly leveraged; amplifies downside in rate rises).
- Cash Flow Pressure: Operating Cash Flow - -HK$780.50 million; Free Cash Flow - -HK$858.95 million (negative cash generation from core operations and after capital expenditures).
- Interest Coverage: Interest Coverage Ratio - -9.30 (operating earnings insufficient to cover interest expense; risk of covenant breaches or refinancing stress).
- Valuation Risk: Trailing P/E - 384.23 (very high relative to fundamentals; potential for sharp valuation correction).
- Business Concentration: Reliance on New Energy and Health & Wellness segments for growth (sector-specific volatility and execution risk).
- Strategic Shift Risk: Moving capital and management focus from green construction to renewable energy introduces multi-sector execution complexity and integration risk.
| Metric | Value | Implication |
|---|---|---|
| Debt-to-Equity Ratio | 267.13% | High leverage; sensitive to interest rate increases |
| Operating Cash Flow | -HK$780.50M | Negative cash from operations; working capital or profitability issues |
| Free Cash Flow | -HK$858.95M | Insufficient cash after capex; potential need for external financing |
| Interest Coverage Ratio | -9.30 | Unable to cover interest; raises default/refinancing concerns |
| Trailing P/E | 384.23 | Potential overvaluation relative to earnings |
| Primary Growth Segments | New Energy; Health & Wellness | Concentration risk; sector cyclicality |
- Refinancing & Liquidity Risk: With negative operating and free cash flows and high leverage, Central Holding Group faces heightened refinancing risk. Adverse market conditions or higher borrowing costs could force equity dilution or distress asset sales.
- Interest Rate Sensitivity: A rising interest rate environment would increase interest burden materially given the 267.13% debt-to-equity ratio and negative interest coverage, compressing margins further.
- Execution Risk from Strategic Pivot: Scaling back green construction while expanding in renewable energy and health sectors requires new capabilities, capital allocation accuracy, regulatory approvals and supply-chain adaptation; missteps may impair projected revenue growth.
- Sector Concentration & Market Volatility: Heavy dependence on new energy and health & wellness exposes revenue to technological shifts, policy changes, commodity price swings and consumer trends specific to those industries.
- Valuation Volatility: A trailing P/E of 384.23 suggests the market is pricing significant growth expectations-any shortfall in execution or earnings could trigger rapid multiple contraction and share-price volatility.
- Operational Cash Strain: Continued negative operating cash flow (-HK$780.50M) and free cash flow (-HK$858.95M) increase the likelihood of funding shortfalls, delayed projects, or renegotiated supplier/contractor terms.
Central Holding Group Co. Ltd. (1735.HK) - Growth Opportunities
Central Holding Group's directional pivot toward renewable energy and health services creates multiple scalable revenue levers and strategic advantages:- Renewable energy focus: strategic shift to high‑efficiency PV battery and component production targeting growing global demand for solar equipment and storage solutions.
- Health & wellness expansion: entry into healthcare consulting and services provides diversification away from cyclical construction and commodity exposure.
- Portfolio refocus: scaling back green construction to concentrate on high‑efficiency PV production aligns capital allocation with higher‑margin, technology‑led segments.
- Balance‑sheet signal: market capitalization of HK$34.21 billion (as of 19 Dec 2025) and enterprise value of HK$36.09 billion indicate investor valuation support for growth initiatives.
- Capacity roadmap: major capacity expansions already completed, with additional PV production projects planned and staged through 2026 to capture near‑term demand.
| Metric / Item | Value / Status |
|---|---|
| Market capitalization (19 Dec 2025) | HK$34.21 billion |
| Enterprise value | HK$36.09 billion |
| Renewable production focus | High‑efficiency PV battery & component manufacturing (major capacity expansions completed) |
| Planned projects | Additional PV production projects scheduled through 2026 (staged expansions) |
| Diversification initiatives | Healthcare consulting & services (new business line expansion) |
| Strategic repositioning | Scaling back green construction to prioritize PV manufacturing and sustainable infrastructure components |
- Revenue mix shift: increasing capital and operational focus on PV battery/component sales should change long‑term revenue composition toward manufacturing and tech‑enabled products.
- Margin potential: high‑efficiency PV components and battery systems generally command higher gross margins than bulk construction; execution on capacity and yield improvements is key.
- Capital deployment: enterprise value near HK$36.09 billion provides a market valuation platform to raise project finance, JV capital, or issue equity for scaling planned 2026 projects.
- Market positioning: concentrating on PV component specialization enhances competitiveness as global solar adoption accelerates, reducing exposure to cyclical construction demand.
- Risk / timing: near‑term execution risk on scheduled 2026 projects and integration risk with new healthcare businesses; monitoring incremental capacity ramp and early revenue from health services is critical.

Central Holding Group Co. Ltd. (1735.HK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.